ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
2,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
3,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
3,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
4,1,Brain stem infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
4,2,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
4,3,Cerebral small vessel ischaemic disease,Central nervous system vascular disorders NEC,Central nervous system vascular disorders,Nerv,N
4,4,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
4,5,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
4,6,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
5,1,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
5,2,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
5,3,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
6,1,Headache,Headaches NEC,Headaches,Nerv,N
7,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
7,2,Testicular germ cell cancer metastatic,Testicular neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
8,1,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
8,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
9,1,Headache,Headaches NEC,Headaches,Nerv,N
10,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,Y
11,1,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
11,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
11,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
12,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
12,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
12,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
13,1,Cardiac death,Death and sudden death,Fatal outcomes,Genrl,Y
14,1,Anal abscess,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
15,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
15,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
16,1,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
17,1,Suspected COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
18,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
19,1,Pruritus genital,Reproductive tract signs and symptoms NEC,Reproductive tract disorders NEC,Repro,N
20,1,Blood triglycerides increased,Triglyceride analyses,Lipid analyses,Inv,N
20,2,Glycosylated haemoglobin increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
20,3,Lentigo maligna,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
20,4,Thyroxine free increased,Thyroid analyses,Endocrine investigations (incl sex hormones),Inv,N
21,1,Dermatitis atopic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
22,1,Folliculitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
23,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
24,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
25,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
25,2,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
25,3,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
26,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
27,1,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
28,1,Pruritus genital,Reproductive tract signs and symptoms NEC,Reproductive tract disorders NEC,Repro,N
29,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
29,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
29,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
30,1,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
30,2,Therapeutic response shortened,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
31,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
32,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
32,2,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
33,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
34,1,Alcohol abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
34,2,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
34,3,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
34,4,Hepatic cirrhosis,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,N
34,5,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
34,6,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
35,1,Erythrodermic psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
36,1,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
37,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
37,2,Respiratory tract congestion,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
37,3,Therapeutic response shortened,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
38,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
39,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
40,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
40,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
41,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
41,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
41,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
41,4,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
41,5,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
42,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
42,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
43,1,Autoimmune pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
43,2,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
43,3,Ear infection,Ear infections,Infections - pathogen unspecified,Infec,N
44,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
44,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
45,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
45,2,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
46,1,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
47,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
47,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
48,1,Autoimmune pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
48,2,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
48,3,Ear infection,Ear infections,Infections - pathogen unspecified,Infec,N
48,4,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
49,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
49,2,Diverticular perforation,"Gastrointestinal ulcers and perforation, site unspecified",Gastrointestinal ulceration and perforation,Gastr,N
49,3,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
50,1,Alcoholic liver disease,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
50,2,Spontaneous bacterial peritonitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
51,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
51,2,Pregnancy,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
52,1,Bone erosion,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
52,2,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
52,3,Foot deformity,Extremity deformities,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
52,4,Joint effusion,Joint related signs and symptoms,Joint disorders,Musc,N
52,5,Osteoarthritis,Osteoarthropathies,Joint disorders,Musc,N
52,6,Red blood cell sedimentation rate increased,Haematological analyses NEC,Haematology investigations (incl blood groups),Inv,N
52,7,Spinal osteoarthritis,Osteoarthropathies,Joint disorders,Musc,N
52,8,Synovitis,Synovial disorders,Synovial and bursal disorders,Musc,N
52,9,Tenosynovitis,Tendon disorders,"Tendon, ligament and cartilage disorders",Musc,N
53,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
53,2,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
54,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
54,2,Hidradenitis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
54,3,Perineal abscess,Muscle and soft tissue infections,Infections - pathogen unspecified,Infec,N
54,4,Perineal disorder,Reproductive tract disorders NEC (excl neoplasms),Reproductive tract disorders NEC,Repro,N
54,5,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
54,6,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
54,7,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
54,8,Vulval disorder,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
55,1,Headache,Headaches NEC,Headaches,Nerv,N
56,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
56,2,Hepatic cirrhosis,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,N
56,3,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
56,4,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
56,5,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
56,6,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
57,1,Mechanical urticaria,Urticarias,Angioedema and urticaria,Skin,N
58,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
59,1,Suicide attempt,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
60,1,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
61,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
61,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
61,3,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
62,1,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
63,1,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
64,1,Tympanic membrane perforation,Tympanic membrane disorders (excl infections),Middle ear disorders (excl congenital),Ear,N
65,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
66,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
67,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
68,1,Psoriatic arthropathy,Psoriatic arthropathies,Joint disorders,Musc,N
69,1,Lung neoplasm malignant,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
70,1,Lung cancer metastatic,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
71,1,Immunoglobulins increased,Immunoglobulin analyses,Immunology and allergy investigations,Inv,N
71,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
71,3,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
72,1,Coronary artery embolism,Coronary artery disorders NEC,Coronary artery disorders,Card,N
72,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
73,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
73,2,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
74,1,Vascular dementia,Dementia (excl Alzheimer's type),Mental impairment disorders,Nerv,N
75,1,Death,Death and sudden death,Fatal outcomes,Genrl,N
76,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
76,2,Symptom recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
77,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
77,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
77,3,Skin abrasion,Skin injuries NEC,Injuries NEC,Inj&P,N
78,1,Immunoglobulins increased,Immunoglobulin analyses,Immunology and allergy investigations,Inv,N
79,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
79,2,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
79,3,Oesophageal achalasia,Gastrointestinal dyskinetic disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
79,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
80,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
80,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
80,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
80,4,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
80,5,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
80,6,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
80,7,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
80,8,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
80,9,Product prescribing issue,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
81,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
81,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
81,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
82,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
83,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
84,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
84,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
84,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
84,4,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
84,5,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
85,1,Hand dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
86,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
86,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
86,3,Pseudomyxoma peritonei,Oncologic complications and emergencies,Neoplasm related morbidities,Neopl,N
87,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
88,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
88,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
88,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
89,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
90,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
91,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
92,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
92,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
92,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
92,4,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
92,5,Joint stiffness,Joint related signs and symptoms,Joint disorders,Musc,N
93,1,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
94,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
94,2,Joint injury,Bone and joint injuries NEC,Bone and joint injuries,Inj&P,N
94,3,Osteoarthritis,Osteoarthropathies,Joint disorders,Musc,N
95,1,Optic nerve injury,Cranial nerve injuries,Injuries NEC,Inj&P,N
95,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
96,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
96,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
96,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
96,4,Faecal calprotectin increased,Faecal analyses NEC,Gastrointestinal investigations,Inv,N
96,5,Sacroiliitis,Arthropathies NEC,Joint disorders,Musc,N
97,1,Prostate cancer,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
98,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
99,1,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
100,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
101,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
101,2,Therapeutic response shortened,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
102,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
102,2,Therapeutic response shortened,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
102,3,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
103,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
103,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
104,1,Pre-existing condition improved,General signs and symptoms NEC,General system disorders NEC,Genrl,N
104,2,Therapeutic response unexpected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
105,1,Device issue,Device issues NEC,Device issues,Prod,N
105,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
106,1,Biliary sepsis,Hepatobiliary and spleen infections,Infections - pathogen unspecified,Infec,N
107,1,Inflammatory bowel disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
108,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
109,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
110,1,Headache,Headaches NEC,Headaches,Nerv,N
111,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
111,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
112,1,Headache,Headaches NEC,Headaches,Nerv,N
113,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
113,2,Basilar migraine,Migraine headaches,Headaches,Nerv,N
113,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
114,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
114,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
114,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
115,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
116,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
117,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
118,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
119,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
120,1,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
121,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
121,2,Therapeutic response shortened,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
122,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
123,1,Eczema nummular,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
123,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
123,3,Skin discomfort,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
123,4,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
124,1,Genital candidiasis,Candida infections,Fungal infectious disorders,Infec,N
124,2,Oral candidiasis,Candida infections,Fungal infectious disorders,Infec,N
125,1,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
126,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
127,1,Retinal injury,Eye injuries NEC,Injuries NEC,Inj&P,N
128,1,Vitiligo,Hypopigmentation disorders,Pigmentation disorders,Skin,N
129,1,Suicide attempt,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
130,1,Charles Bonnet syndrome,Visual disorders NEC,Vision disorders,Eye,N
130,2,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
130,3,Retinal detachment,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
130,4,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
131,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
131,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
131,3,Psoriatic arthropathy,Psoriatic arthropathies,Joint disorders,Musc,N
132,1,Encephalitis viral,Viral infections NEC,Viral infectious disorders,Infec,N
133,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
134,1,Encephalitis viral,Viral infections NEC,Viral infectious disorders,Infec,N
135,1,Encephalitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
136,1,Blood test,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
137,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
138,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
139,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
139,2,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
140,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
140,2,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
141,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
141,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
141,3,Headache,Headaches NEC,Headaches,Nerv,N
141,4,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
141,5,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
142,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
143,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
143,2,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
144,1,Colon cancer,Colorectal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
145,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
146,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
147,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
148,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
149,1,Fournier's gangrene,Muscle and soft tissue infections,Infections - pathogen unspecified,Infec,N
150,1,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
150,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
150,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
151,1,Cerebral haematoma,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
152,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
152,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
153,1,Toothache,Dental pain and sensation disorders,Dental and gingival conditions,Gastr,N
154,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
154,2,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
155,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
156,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
157,1,Headache,Headaches NEC,Headaches,Nerv,N
157,2,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
157,3,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
158,1,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
159,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
159,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
159,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
160,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
160,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
160,3,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
161,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
162,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
163,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
163,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
164,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
165,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
165,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
165,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
166,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
167,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
167,2,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
167,3,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
168,1,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
169,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
